Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Adamis Pharma (ADMP)
NASDAQ:ADMP
Adamis Pharma (ADMP) Stock Price & Analysis
1,085 Followers
ADMP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.12 - $0.73
Previous Close$0.23
Volume774.44K
Average Volume (3M)623.49K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$2.42M
Total Debt (Recent Filing)$432.02K
Price to Earnings (P/E)-0.5
Beta0.73
Next EarningsMar 30, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)-0.48
Shares Outstanding149,983,265
R-Squared0.05
Standard Deviation0.33
10 Day Avg. Volume497,574
30 Day Avg. Volume623,485
Price to Book (P/B)10.57
Price to Sales (P/S)12.17
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
Alpha-0.02
Number of Analyst Covering0
Adamis Pharma News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ADMP FAQ
What was Adamis Pharma’s price range in the past 12 months?
Adamis Pharma lowest stock price was $0.12 and its highest was $0.73 in the past 12 months.
What is Adamis Pharma’s market cap?
Currently, no data Available
When is Adamis Pharma’s upcoming earnings report date?
Adamis Pharma’s upcoming earnings report date is Mar 30, 2023 which is in 55 days.
How were Adamis Pharma’s earnings last quarter?
Adamis Pharma released its earnings results on Nov 14, 2022. The company reported -$0.03 earnings per share for the quarter, the consensus estimate of -$0.03 by $0.
Is Adamis Pharma overvalued?
According to Wall Street analysts Adamis Pharma’s price is currently Overvalued.
Does Adamis Pharma pay dividends?
Adamis Pharma does not currently pay dividends.
What is Adamis Pharma’s EPS estimate?
Adamis Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Adamis Pharma have?
Adamis Pharma has 149,983,260 shares outstanding.
What happened to Adamis Pharma’s price movement after its last earnings report?
Adamis Pharma reported an EPS of -$0.03 in its last earnings report, expectations of -$0.03. Following the earnings report the stock price went up 22.222%.
Which hedge fund is a major shareholder of Adamis Pharma?
Among the largest hedge funds holding Adamis Pharma’s share is Greenlight Capital Inc. It holds Adamis Pharma’s shares valued at N/A.
---
Adamis Pharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 292.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.2%
Last 30 Days ▼ 5.1%
Last 30 Days ▼ 5.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-63.02%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-73.07%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Adamis Pharma
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA.
---
Elite Pharmaceuticals
―
Cumberland Pharmaceuticals
―
Item 9 Labs
―
Akari Therapeutics
―
Nutriband
―
---